FocusOn Neurology
  • Biozone
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • Myasthenia Gravis
  • Neurofibromatosis
  • hATTR-PN
  • MDA 2024
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights
  • Parkinson's Disease
  • Biozone
  • Multiple Sclerosis
  • Migraine Research Library
  • LGS & Dravet Syndrome
  • Tardive Dyskinesia
  • hATTR-PN
  • CIDP Awareness Month
  • Alzheimer's Awareness Month
  • Anticoagulation Reversal Knowledge & Learning Center
  • PNS 2024 Annual Meeting Highlights

Advanced Search

Advanced Search

  • Featured:
  • Myasthenia Gravis
  • Neurofibromatosis
  • MDA 2024
  • Parkinson's Disease

Atypical cavernous hemangioma clinically masquerading as a plexiform Orbitofacial neurofibromatosis: A case report

October-December 2024

Share:
Neurofibromatosis Resource Center Home Page

Read Full Article

Abstract

Orbitofacial neurofibromatosis type 1 (OFNF) is a rare and unique variant of neurofibromatosis type 1. This case report aims to highlight the clinical observations and surgical management of a patient with a large atypical cavernous hemangioma, which was masquerading as a plexiform orbitofacial neurofibroma. A 35‑year‑old female presented with a huge orbitofacial mass, which was clinically and radiologically diagnosed as an orbitofacial neurofibroma involving the right eye and face. A detailed history and physical examination were performed, and a plastic surgery consultation was sought. The patient was diagnosed with OFNF. After conducting an orbit and brain MRI, along with other routine investigations, surgery was planned. The patient underwent right eye exenteration with an ipsilateral pedicled temporoparietal fascia flap covered with a split‑thickness skin graft. Histopathology revealed the mass to be a cavernous hemangioma. In such a rare condition, an incisional biopsy may guide further definitive surgical treatment, ensuring that the final outcome involves minimum possible disfiguration and has the least impact on the quality of life of the patient.

Share

Modal body text goes here.

FocusOn logo
  • Articles
  • Multimedia
  • Blog
  • Resources
  • About FocusOn
  • Privacy Policy
  • Terms of Use

© 2025 Wolters Kluwer. All right reserved.

Your Privacy

To give you the best possible experience we use cookies and similar technologies. We use data collected through these technologies for various purposes, including to enhance website functionality, remember your preferences, show the most relevant content, and show the most useful ads. You can select your preferences by clicking the link. For more information, please review our Privacy and Cookie Policy.

|
|

Cookie Policy

Information about our use of cookies

Wolters Kluwer ("we" or "us") wants to inform you about the ways we process your personal information. In this Privacy & Cookie Notice we explain what personal information we collect, use and disclose.

Personal information means any data relating to an individual who can be identified, directly or indirectly, based on that information. This may include information such as names, contact details, (online) identification data, online identifiers, or other characteristics specific to that individual.

Read More